• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

316 例 3 岁以下儿童肝母细胞瘤的临床特征和预后因素-14 年回顾性单中心研究。

Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.

机构信息

Department of Pediatrics, Beijing Tongren Hospital Capital Medical University, No. 1 Dongjiaominxiang Dongcheng District, Beijing, 100730, China.

出版信息

BMC Pediatr. 2021 Apr 13;21(1):170. doi: 10.1186/s12887-021-02630-2.

DOI:10.1186/s12887-021-02630-2
PMID:33849474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8042893/
Abstract

BACKGROUND

The aim of the present study was to summarize the clinical characteristics of in children aged under 3 years and analyze the related factors affecting the prognosis.

METHODS

The clinical data of 316 children aged under 3 years (192 males and 124 females) who were admitted to Beijing Tongren Hospital with a pathological diagnosis of HB between May 2005 and May 2019 were analyzed retrospectively. The factors influencing the therapeutic effects on and survival of HB in children with HB were analyzed.

RESULTS

(1) The median age of the enrolled patients was 1.45 years. The most common initial symptom was an abdominal mass (69.0%). The average serum alpha-fetoprotein (AFP) level and platelet count at the initial visit were (97,406.5 ± 5022.8) ng/mL and (418 ± 206) × 10/L, respectively. The epithelial type was the main pathological type (51.9%). According to the PRETEXT preoperative typing system, the most common stage was stage III (57.0%), whereas according to the postoperative Evans staging system, the most common stage was stage IV (41.8%). At the initial visit, 62 cases (19.6%) had vascular invasion, 52 cases (16.5%) had extrahepatic tumor extension, and 20 cases (6.3%) had tumor rupture. Distant metastasis occurred in 132 cases, and the most common metastatic site was the lung (80.3%). The incidence in East China was relatively high (35.4%). (2) The children were followed up until May 2020 (the median follow-up duration was 62 months). It was found that 194 patients had complete remission and 62 had partial remission. The Kaplan-Meier survival analysis showed that the overall survival was 95.3, 88.2, and 79.8% at 1 year, 3 years, and 5 years, respectively, and the event-free survival was 91.1, 83.2, and 75.1%, respectively. The Cox regression analysis showed that AFP level, platelet count, PRETEXT IV, vascular invasion, and distant metastasis at the initial visit were independent risk factors for the prognosis of children with HB (p < 0.05 in all).

CONCLUSION

The prognosis of HB was correlated with the AFP level, platelet count, PRETEXT staging, vascular invasion, and distant metastasis at initial diagnosis.

摘要

背景

本研究旨在总结 3 岁以下儿童 HB 的临床特征,并分析影响预后的相关因素。

方法

回顾性分析 2005 年 5 月至 2019 年 5 月期间因病理诊断为 HB 而在北京同仁医院住院的 316 例 3 岁以下儿童的临床资料。分析影响 HB 患儿治疗效果及生存的相关因素。

结果

(1)纳入患者的中位年龄为 1.45 岁。最常见的首发症状为腹部包块(69.0%)。初诊时血清甲胎蛋白(AFP)水平和血小板计数平均值分别为(97406.5±5022.8)ng/mL和(418±206)×10/L。上皮型为主要病理类型(51.9%)。根据 PRETEXT 术前分型系统,最常见的分期为 III 期(57.0%),而根据术后 Evans 分期系统,最常见的分期为 IV 期(41.8%)。初诊时 62 例(19.6%)有血管侵犯,52 例(16.5%)有肝外肿瘤播散,20 例(6.3%)有肿瘤破裂。132 例发生远处转移,最常见的转移部位为肺(80.3%)。华东地区发病率相对较高(35.4%)。(2)患儿随访至 2020 年 5 月(中位随访时间 62 个月)。结果显示,194 例患儿完全缓解,62 例部分缓解。Kaplan-Meier 生存分析显示,患儿的总生存率分别为 1 年、3 年和 5 年时的 95.3%、88.2%和 79.8%,无事件生存率分别为 1 年、3 年和 5 年时的 91.1%、83.2%和 75.1%。Cox 回归分析显示,初诊时 AFP 水平、血小板计数、PRETEXT Ⅳ期、血管侵犯和远处转移是影响 HB 患儿预后的独立危险因素(p 值均<0.05)。

结论

HB 的预后与 AFP 水平、血小板计数、PRETEXT 分期、血管侵犯和初诊时远处转移有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/a19eb1f7a5cd/12887_2021_2630_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/73d65775bc03/12887_2021_2630_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/70f8942ec565/12887_2021_2630_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/82f54fe18a10/12887_2021_2630_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/5cf869b1ec73/12887_2021_2630_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/572f6b61ee34/12887_2021_2630_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/a19eb1f7a5cd/12887_2021_2630_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/73d65775bc03/12887_2021_2630_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/70f8942ec565/12887_2021_2630_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/82f54fe18a10/12887_2021_2630_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/5cf869b1ec73/12887_2021_2630_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/572f6b61ee34/12887_2021_2630_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d2a/8042893/a19eb1f7a5cd/12887_2021_2630_Fig6_HTML.jpg

相似文献

1
Clinical characteristics and prognostic factors of hepatoblastoma in 316 children aged under 3 years - a 14-year retrospective single-center study.316 例 3 岁以下儿童肝母细胞瘤的临床特征和预后因素-14 年回顾性单中心研究。
BMC Pediatr. 2021 Apr 13;21(1):170. doi: 10.1186/s12887-021-02630-2.
2
[Clinical features and prognostic analysis of hepatoblastoma in children under six years old].[6岁以下儿童肝母细胞瘤的临床特征及预后分析]
Zhonghua Gan Zang Bing Za Zhi. 2021 Nov 20;29(11):1063-1068. doi: 10.3760/cma.j.cn501113-20201211-00648.
3
A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.新的儿童肝母细胞瘤风险分层系统及其对预后评估的意义——来自单中心的 14 年回顾性研究。
BMC Cancer. 2021 Apr 13;21(1):397. doi: 10.1186/s12885-021-08095-x.
4
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.儿童肝母细胞瘤的风险分层分期:来自国际儿童肝脏肿瘤协作组的统一分析
Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22.
5
Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study.儿童晚期肝母细胞瘤的临床疗效及预后因素:一项6年回顾性研究
Asian Pac J Cancer Prev. 2013;14(8):4583-9. doi: 10.7314/apjcp.2013.14.8.4583.
6
[Clinical characteristics and prognosis of 83 children with newly treated hepatoblastoma].83例初治儿童肝母细胞瘤的临床特征与预后
Zhonghua Er Ke Za Zhi. 2022 Feb 2;60(2):108-113. doi: 10.3760/cma.j.cn112140-20210601-00472.
7
Clinical Characteristics and Prognosis Analysis of Infantile Hepatoblastoma-A 15-Year Retrospective Single-Center Study.小儿肝母细胞瘤的临床特征与预后分析——一项15年的回顾性单中心研究
Cancer Manag Res. 2021 Apr 13;13:3201-3208. doi: 10.2147/CMAR.S302078. eCollection 2021.
8
Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.肝母细胞瘤患儿的预处理预后因素及治疗结果:来自德国儿童肝脏肿瘤协作研究HB 94的报告
Cancer. 2002 Jul 1;95(1):172-82. doi: 10.1002/cncr.10632.
9
Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.肝母细胞瘤患儿的预后分层:SIOPEL 经验。
Eur J Cancer. 2012 Jul;48(10):1543-9. doi: 10.1016/j.ejca.2011.12.011. Epub 2012 Jan 13.
10
Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.晚期肝母细胞瘤的手术治疗策略:切除与移植。
Pediatr Blood Cancer. 2018 Dec;65(12):e27383. doi: 10.1002/pbc.27383. Epub 2018 Aug 7.

引用本文的文献

1
Hepatoblastoma regional trends: dynamic SDI & joinpoint regression analysis.肝母细胞瘤的区域趋势:动态社会人口指数与连接点回归分析
BMC Cancer. 2025 Jul 5;25(1):1148. doi: 10.1186/s12885-025-14566-2.
2
Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study.基于人群的研究:构建和验证预测肝母细胞瘤患者生存的列线图预后模型。
Updates Surg. 2024 Aug;76(4):1223-1234. doi: 10.1007/s13304-024-01814-6. Epub 2024 May 25.
3
The roles of chaplains in dispelling cancer myths in Nigeria: A narrative review.

本文引用的文献

1
How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.同步性肺转移如何影响肝母细胞瘤患儿的外科治疗?文献综述与最新进展
Cancers (Basel). 2019 Oct 31;11(11):1693. doi: 10.3390/cancers11111693.
2
A Synopsis of Pediatric Patients With Hepatoblastoma and Wilms Tumor: NSQIP-P 2012-2016.小儿肝母细胞瘤和肾母细胞瘤患者概要:2012-2016 年 NSQIP-P。
J Surg Res. 2019 Dec;244:338-342. doi: 10.1016/j.jss.2019.06.064. Epub 2019 Jul 13.
3
Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.
尼日利亚牧师在消除癌症误解方面的作用:一项叙述性综述。
Health Sci Rep. 2023 Aug 21;6(8):e1502. doi: 10.1002/hsr2.1502. eCollection 2023 Aug.
4
Bone metastases in hepatoblastoma, an unusual presentation. Case report and review of the literature.肝母细胞瘤中的骨转移,一种罕见表现。病例报告及文献综述。
Radiol Case Rep. 2022 Sep 13;17(11):4272-4275. doi: 10.1016/j.radcr.2022.08.025. eCollection 2022 Nov.
中国单中心儿童肝母细胞瘤的回顾性分析。
Clin Oncol (R Coll Radiol). 2019 Jul;31(7):471-478. doi: 10.1016/j.clon.2019.03.044. Epub 2019 Apr 15.
4
Contemporary management of hepatoblastoma.肝细胞瘤的当代治疗。
Curr Opin Organ Transplant. 2019 Apr;24(2):113-117. doi: 10.1097/MOT.0000000000000618.
5
Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.儿童肝母细胞瘤的风险分层分期:来自国际儿童肝脏肿瘤协作组的统一分析
Lancet Oncol. 2017 Jan;18(1):122-131. doi: 10.1016/S1470-2045(16)30598-8. Epub 2016 Nov 22.
6
Pediatric hepatoblastoma: diagnosis and treatment.小儿肝母细胞瘤:诊断与治疗。
Transl Pediatr. 2014 Oct;3(4):293-9. doi: 10.3978/j.issn.2224-4336.2014.09.01.
7
The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model.儿童肝肿瘤国际协作组(CHIC):新型全球罕见肿瘤数据库揭示了肝母细胞瘤新的预后因素并成为一种研究模式。
Eur J Cancer. 2016 Jan;52:92-101. doi: 10.1016/j.ejca.2015.09.023. Epub 2015 Dec 1.
8
Efficacy of neoadjuvant therapy and surgical rescue for locally advanced hepatoblastomas: 10 year single-center experience and literature review.新辅助治疗及手术挽救对局部晚期肝母细胞瘤的疗效:单中心10年经验及文献综述
World J Gastroenterol. 2014 Aug 7;20(29):10137-43. doi: 10.3748/wjg.v20.i29.10137.
9
Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy.肝母细胞瘤的最新进展:病理学、遗传学、风险分层及化疗
Curr Opin Pediatr. 2014 Feb;26(1):19-28. doi: 10.1097/MOP.0000000000000046.
10
Predictors of survival and incidence of hepatoblastoma in the paediatric population.儿童人群中肝母细胞瘤的生存和发病预测因素。
HPB (Oxford). 2013 Oct;15(10):741-6. doi: 10.1111/hpb.12112. Epub 2013 Apr 22.